Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma
Jayashree Kalpathy–Cramer(University of Colorado Denver), Elizabeth R. Gerstner(University of California, Los Angeles), Alona Muzikansky(Johns Hopkins University), J.G. Evans(University of Virginia), Patrick Y. Wen(Dana-Farber Cancer Institute), Dan G. Duda(Harvard University), Stephen Stufflebeam(Athinoula A. Martinos Center for Biomedical Imaging), Vyshak Chandra(Athinoula A. Martinos Center for Biomedical Imaging), Jörg Dietrich(Massachusetts General Hospital), Yangming Ou(Boston Children's Hospital), Tracy T. Batchelor(Brigham and Women's Hospital), Linda Douw(Amsterdam UMC Location Vrije Universiteit Amsterdam), Xiao Da(Athinoula A. Martinos Center for Biomedical Imaging), Bruce R. Rosen(Massachusetts General Hospital), Xuezhu Cai(Boston University), Kyrre E. Emblem(Oslo University Hospital)
Cited by 82
Related Papers
3D Slicer as an image computing platform for the Quantitative Imaging Network
|Magnetic Resonance Imaging|2012|9.1k
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
|IEEE Transactions on Medical Imaging|2014|6.7k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
|New England Journal of Medicine|2008|1.6k